A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

BACKGROUND: Cognitive deficits in schizophrenia are associated with psychosocial deficits that are primarily responsible for the poor long-term outcome of this disease. Auditory sensory gating P50 deficits are correlated with neuropsychological deficits in attention, one of the principal cognitive d...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shiina, Akihiro, Shirayama, Yukihiko, Niitsu, Tomihisa, Hashimoto, Tasuku, Yoshida, Taisuke, Hasegawa, Tadashi, Haraguchi, Tadashi, Kanahara, Nobuhisa, Shiraishi, Tetsuya, Fujisaki, Mihisa, Fukami, Goro, Nakazato, Michiko, Iyo, Masaomi, Hashimoto, Kenji
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Primary research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2901366/
https://ncbi.nlm.nih.gov/pubmed/20573264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-859X-9-27
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky